12 Sep 2023 by admin in UncategorizedComments 科越医药在 2023 年第 29 届国际补体大会上公布了 KP104 I 期 SYNERGY-1 临床试验 的 完整数据,以及与 Lübeck 大学合作在自身免疫性皮肤病模型中的临床前研究成果
07 Sep 2023 by admin in UncategorizedComments NextCure and Nordic Bioscience Publish Review Article on the Regulation of Tumor Immunity by Tumor Collagen
05 Sep 2023 by admin in UncategorizedComments Zenas BioPharma Announces Strategic License and Collaboration Agreement with Bristol Myers Squibb
04 Sep 2023 by admin in UncategorizedComments Crescendo Biologics Wins Significant European Patent Office Ruling Related to the Engineering of Immunoglobulin Therapeutics
14 Aug 2023 by admin in UncategorizedComments Design Therapeutics Reports Initial Results from Phase 1 Multiple-Ascending Dose Study of DT-216 for the Treatment of Friedrich Ataxia
24 Jul 2023 by admin in UncategorizedComments Crescendo Biologics secures $32M and announces expansion of CB307 Phase 1b trial in PSMA+ solid tumours
11 Jul 2023 by admin in UncategorizedComments Adicet Announces Appointment of Katie Peng to the Board of Directors
09 May 2023 by admin in UncategorizedComments Interius BioTherapeutics Announces Successful Manufacturing Partnership with WuXi Advanced Therapies
27 Apr 2023 by admin in UncategorizedComments Crescendo Biologics appoints Angus Hone as Chief Financial Officer
31 Jan 2023 by admin in UncategorizedComments Crescendo Biologics is category winner for Biopharma and Vaccines in 2023 UK DIT Life Sciences Innovator Showcase
26 Jan 2023 by admin in UncategorizedComments Syros Receives Fast Track Designation from the FDA for Tamibarotene for the Treatment of Higher-Risk Myelodysplastic Syndrome
20 Dec 2022 by admin in UncategorizedComments 科越医药宣布在中国和澳大利亚启动 KP104 在 IgA 肾病(IgAN)和 C3 肾小球病 (C3G)的 II 期临床试验
09 Dec 2022 by admin in UncategorizedComments Arcellx And Kite Announce Strategic Collaboration To Co- Develop And Co-Commercialize Late-Stage Clinical CART- DdBCMA In Multiple Myeloma
02 Dec 2022 by admin in UncategorizedComments 健新原力全新 GMP 生产基地&公司总部大楼(中国,杭州)投入 运营,进一步为全球客户提供 RNA、细胞和基因疗法的 CDMO 一 站式服务
30 Nov 2022 by admin in UncategorizedComments 科越医药宣布 KP104 用于治疗阵发性睡眠性血红蛋白尿症(PNH)的 II 期临床 首个队 列的患者已完成第一次给药
30 Nov 2022 by admin in UncategorizedComments Adicet Bio Appoints Nancy Boman, M.D., Ph.D., as Senior Vice President and Chief Regulatory Officer
17 Nov 2022 by admin in UncategorizedComments Laronde Appoints Pablo J. Cagnoni as Chief Executive Officer
15 Nov 2022 by admin in UncategorizedComments NextCure and LegoChem Biosciences Enter into Collaboration and Co-Development Agreement to Develop Antibody Drug Conjugates
14 Nov 2022 by admin in UncategorizedComments Syros Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides a Corporate Update
14 Nov 2022 by admin in UncategorizedComments Arcellx Reports Third Quarter 2022 Financial Results And Business Progress
08 Nov 2022 by admin in UncategorizedComments Tempest Reports Third Quarter 2022 Financial Results and Provides Business Update
08 Nov 2022 by admin in UncategorizedComments Adicet Reports Third Quarter 2022 Financial Results and Provides Business Updates
07 Nov 2022 by admin in UncategorizedComments Zenas BioPharma Secures $118 Million to Advance Its Broad Pipeline of Autoimmune Disease Therapeutics